News and blog

Keeping you up to date with the latest developments in science, policy and health
S1R1C1
 
BlogGenomics, research, health and policy: new UK government directionsThursday December 22, 2022New policy releases from the UK Department of Health and Social Care review recent developments and set out plans
BlogRevealing the history of genetics and genomics policy in BritainTuesday December 13, 2022The PHG Foundation hosts showcase for new book on the history of policy supporting genetics and genomics
BlogPHG Foundation seeks new Director to help science work for healthMonday November 21, 2022A unique opportunity has arisen for an exceptional individual with experience working at the interface between research and health policy to lead and grow the PHG Foundation.
BlogExamining whether viruses can combat antimicrobial resistanceThursday November 17, 2022The UK House of Commons Science and Technology Committee has announced a new inquiry that will explore the antimicrobial potential of bacteriophages (phages), a topic explored by the PHG Foundation in our 2021 policy briefing on phage therapy.
BlogMaking the most of genomics: supporting clinical research and careThursday November 10, 2022It is widely recognised that genomics offers increasing capacity to understand, predict, prevent, diagnose and manage diseases with greater precision.
BlogCancer, screening, and polygenic scoresTuesday November 1, 2022Screening is an important aspect of disease control and can support diagnosis and treatment of early stage disease.
BlogCAR-T cell therapy for lupusWednesday October 19, 2022CAR-T cell therapy involves genetically engineering T cells, a type of immune cell, so that they respond to a prespecified molecular marker, or antigen.
BlogAccelerating genomic medicineMonday October 17, 2022A new NHS England (NHSE) strategy, Accelerating genomic medicine in the NHS, was released on 12th October, alongside the first NHS Genomics Healthcare Summit in London.
BlogBiomarkers and cancer precision medicineWednesday August 17, 2022A set of consensus statements on the use of biomarkers in cancer research and treatment were released this month. We discuss what these mean.
S2R1C1